Observational studyLeukemia & lymphoma2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
Observational study in Leukemia & lymphoma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 43 citations in OpenAlex.
- Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.Journal of clinical medicine · 2026Review
- Anticoagulant therapy in patients with cancer and thrombocytopenia.Journal of thrombosis and thrombolysis · 2025Review
- Risk of venous thromboembolism after discontinuing prophylactic or therapeutic anticoagulation in patients with haematologic malignancies because of thrombocytopenia.Journal of thrombosis and thrombolysis · 2025Article
- Clinical Challenges in Treating Cancer-Associated Thrombosis: A Clinically Oriented Review.Acta haematologica · 2025Review
- Clinical analysis of bleeding and thrombotic events in haematological-oncology patients with severe thrombocytopenia and a high risk of thrombosis.Scientific reports · 2024Article
- Cancer-associated thrombosis in hematologic malignancies.International journal of hematology · 2024Review
- Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis.Research and practice in thrombosis and haemostasis · 2022Article
- EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer.HemaSphere · 2022Article
- Management of cancer-associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement.Research and practice in thrombosis and haemostasis · 2022Article
- Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.Blood advances · 2021Observational
- Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.Blood advances · 2021Article
- Challenges and Advances in Managing Thrombocytopenic Cancer Patients.Journal of clinical medicine · 2021Review
- HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment.Blood advances · 2021Article
- Pulmonary Thromboembolism in Immune Thrombocytopenia: A Report of Five Cases and a Review of the Literature.International journal of general medicine · 2021Article
- Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality.TH open : companion journal to thrombosis and haemostasis · 2020Article
- Cancer-associated thromboembolism: antithrombotic management of hospitalized patients.Journal of thrombosis and thrombolysis · 2020Observational
- Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.Blood transfusion = Trasfusione del sangue · 2019Review
- Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants.Journal of Korean medical science · 2019Review
- Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review.Research and practice in thrombosis and haemostasis · 2018Article
- Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.Journal of thrombosis and thrombolysis · 2017Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
The safety and efficacy of anticoagulation for venous thromboembolism (VTE) at times of severe thrombocytopenia is unclear. In this retrospective study, we evaluated patients with hematologic malignancy and either (1) acute or chronic VTE on anticoagulation before platelet count dropped below 50 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.